I6T-MC-AMAN
| abstract | A Phase 3, Multicenter, Randomized, Double-Blind, Parallel, Placebo-Controlled Induction Study of Mirikizumab in Conventional-Failed and Biologic-Failed Patients with Moderately to Severely Active Ulcerative Colitis LUCENT 1 |
| type of project | clinical studies |
| status | automatically closed |
| start of project | 2018 |
| end of project | 2021 |
| responsible person | Prof. Dr. Stephan Brand |